PQ 141
141. Deputy Gerry Adams asked the Minister for Health why Bevacizumab which is used to treat breast, lung, renal and ovarian cancer costs €1,319 in Ireland as against €1,085 in the United Kingdom, if he has queried this price difference with the manufacturer and supplier of this drug; and if he will make a statement on the matter. [44448/15]
Introduced
10 December 2015
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
10 December 2015
Summary
141. Deputy Gerry Adams asked the Minister for Health why Bevacizumab which is used to treat breast, lung, renal and ovarian cancer costs €1,319 in Ireland as against €1,085 in the United Kingdom, if he has queried this price difference with the manufacturer and supplier of this drug; and if he will make a statement on the matter. [44448/15]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Prices
Medicinal Products Prices
xml · EN · 10 December 2015
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2015-12-10/141/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2015-12-10/pq_141